The Office of Drug Control (ODC) has announced membership for the third tenure of the Australian Advisory Council on the Medicinal Use of Cannabis.
The council, established in 2016, provides advice to the federal health minister on issues relating to the medicinal use of cannabis in accordance with the Therapeutic Goods Act 1989 and the Narcotic Drugs Act 1967.
It advises on issues including the cultivation and manufacture of medicinal cannabis, evidence supporting its use for various conditions and patient groups, as well as prescribing guidelines and the Authorised Prescriber and Special Access Scheme schemes.
The council comprises 15 members made up of medical professionals, government representatives, patient groups and legal experts with experience in cancer, epilepsy, palliative care, public health and policy, chronic pain, multiple sclerosis, law, pharmacology and toxicology.
Four members from the previous council will continue to serve, including chair Professor James Angus AO. Epilepsy Action Australia CEO Carol Ireland has stepped down after serving two terms.
To view the new council membership, click here.